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Abstract 
 
A square-wave voltammetric (SWV) method and a flow injection analysis system with amperometric detection were 
developed for the determination of tramadol hydrochloride. The SWV method enables the determination of tramadol 
over  the  concentration  range  of  15 -75  mM  with  a  detection  limit  of  2.2  mM.  Tramadol  could  be  determined  
in concentrations between 9 and 50 mM at a sampling rate of 90 h-1, with a detection  limit of 1.7 mM using the 
flow injection system. The electrochemical methods developed were successfully applied to the determination of 
tramadol in 
pharmaceutical dosage forms, without any pre-treatment of the samples. Recovery trials were performed to assess the 
accuracy of the results; the values were between 97 and 102% for both methods. 
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1. Introduction 
 
Tramadol is a synthetic centrally acting analge- 
sic agent with two distinct, synergistic mechanisms 
of action (Fig. 1). It is both a weak opioid agonist 
with selectivity for the m-receptor and a weak 
inhibitor of the reuptake of noradrenaline and 
serotonin [1]. In several controlled clinical studies, 
oral  and  parenteral  tramadol  effectively relieved 
 
 
moderate to severe postoperative pain associated 
with surgery. Its overall analgesic efficacy was 
comparable to that achieved using equianalgesic 
doses of morphine or alfentanil  [1]. 
The excellent efficacy of tramadol for the 
management of moderate to severe pain associated 
with no clinically significant effects on respiratory 
or cardiovascular parameters,  unlike  other 
opioids, and lower potential for producing  abuse 
or dependence led to the appearance of several 
pharmaceutical dosage forms in the market. 
Nevertheless few methodologies has been pro- 
posed for its determination, which could be related 
with the fact of being a relatively new drug and not 
 
  
 
yet  included  in  the  pharmacopoeias.  Most  of  the 
analytical methods available in literature are based 
in  chromatographic  procedures,  such  as  HPLC 
and capillary electrophoresis, being used to quan- 
tify tramadol in different biological fluids, namely 
urine, plasma and whole blood samples [2 -/5]. For 
determination  of  tramadol  in  pharmaceutical  do- 
sage   forms   few   analytical   methodologies   were 
proposed  and  are  mainly  based  in  spectrophoto- 
metry  [6,7],  HPLC  [8],  capillary  isotachophoresis 
[9] and potentiometry [10]. 
Although electrochemical methods have already 
proved to be very useful in the field of drug 
analysis due to their simplicity, low cost and 
relatively short analysis  time  when  compared 
with other techniques, any  electroanalytical 
method have been proposed for the determination 
of tramadol in pharmaceutical dosage   forms. 
An investigation has been performed on the 
electrochemical behaviour of tramadol at a glassy 
carbon electrode. The results were applied in the 
development of a square-wave voltammetric 
(SWV) method for determination of tramadol in 
pharmaceutical dosage forms. In order to set up an 
analytical procedure that could be easily used in 
the quality control, a flow injection analysis 
manifold with amperometric detection was also 
established. 
 
 
2. Experimental 
 
2.1. Apparatus 
 
Voltammetric measurements were performed on 
a 663 VA Metrohm system containing a glassy 
carbon working electrode (Metrohm, d =2.0 mm), 
a glassy carbon rod counter electrode (Metrohm) 
and a Ag/AgCl (3 M KCl) reference electrode 
(Metrohm)   attached   to  an  Autolab   PSTAT  10 
 
 
Fig. 1.  Chemical structure of  Tramadol. 
 
 
 
Fig.  2.  Flow  injection  analysis  manifold  used  for  tramadol 
determination:  A,  sample;  B,  peristaltic  pump;  E;  inlet  for 
borate buffer support electrolyte; Q 1, flow rate (2.4 ml min-1); 
V, injection valve (80 ml); R, mixing coil (35 cm); WJD, wall-jet 
electrochemical detector; D, outlet for waste. 
 
potentiostat/galvanostat running with model GPES 
version 3 software (EcoChimie,  Netherlands). 
The FIA system components were arranged as 
shown schematically in Fig. 2. A Gilson   Minipuls 
3 peristaltic pump equipped with Gilson PVC 
pumping tubes  propelled  the  solutions.  The 
pump was connected to a Rheodyne 5020 valve 
used to inject the solutions. An electrochemical 
system consisting of a VA 641 Metrohm potentio- 
stat and a 656 Metrohm electrochemical wall-jet 
cell was used as the detector. The cell is composed 
by three electrodes, a Metrohm glassy carbon 
electrode as the working electrode, a  Metrohm 
gold electrode as the auxiliary electrode and a 
Metrohm Ag/AgCl (3 M KCl) as the reference 
electrode. Omnifit Teflon tubing (0.8-mm i.d.) and 
Gilson end fittings as well as home-made dampers 
drilled from perspex [11] were used to connect the 
different manifold components. The analytical 
signals were recorded in a Kipp and Zonen (model 
BD 112) strip chart  recorder. 
The glassy carbon working electrodes used were 
manually cleaned and polished every day with an 
abrasive surface, first with Al2O3 (BDH) and then 
with water only. After polishing, the electrode 
surface was thoroughly washed with deionised 
water. 
A Metrohm E520 pH-meter and a glass elec- 
trode were used for the pH   measurements. 
 
2.2. Reagents and solutions 
 
All  chemicals  used  were  of  analytical  reagent 
grade and were employed without further purifica- 
tion. Deionised water with a specific conductance 
less than 0.1 mS cm-1  was used throughout. 
Buffer solutions used in voltammetric studies 
were prepared as described elsewhere [12]. 
 Borate buffer (pH 9.3; 0.1 M) solution was 
prepared diluting 500 ml of 0.025  M sodium 
borate (Merck) and 30 ml of 0.1 M sodium 
hydroxide (Merck) in 1 l of  water. 
Tramadol hydrochloride was  kindly  provided 
by Tecnifar (Lisbon, Portugal); dosage forms 
containing tramadol were purchased from com- 
mercial sources. 
 
2.3. General procedure 
 
2.3.1. Square-wave voltammetric method 
A 2.4 mM stock standard solution of tramadol 
hydrochloride  was  prepared  in  deionised  water. 
Portions  (60 -/300  ml)  of  this  solution,  accurately 
measured, were added at electrochemical cell to 10 
ml  of  borate  buffer  (pH  9.3;  0.1  M).  The  peak 
current    obtained    was    measured    and    plotted 
against  the  concentration  of  tramadol  to  obtain 
the  standard  calibration  graph.  The  same  proce- 
dure was followed for sample analysis. 
 
2.3.2. Flow injection method 
A stock standard solution (2.4 mM) of tramadol 
hydrochloride was prepared. Five standard solu- 
tions, between 9 and 50 mM, were prepared by 
careful dilution of the stock solution with the 
borate buffer supporting electrolyte. These solu- 
tions were inserted, via injection valve, in the FIA 
system and the peak heights obtained were mea- 
sured and plotted against the concentration of 
tramadol to obtain the standard calibration graph. 
All these solutions were prepared daily. The same 
procedure was followed for sample  analysis. 
 
2.3.3. Sample preparation 
The determination of  tramadol  was performed 
in different formulations (capsules, tablets, am- 
poules and oral solution) that are commercially 
available  in Portugal. 
The content of 10 capsules or tablets were finely 
powdered and thoroughly mixed. An accurately 
weighed amount of powder equivalent to 50 mg of 
tramadol hydrochloride was dissolved in the 
supporting electrolyte solution (pH 9.3). Filtration 
of solution through Whatman No. 42 filter was 
performed to remove any remaining insoluble 
matter. 
 
The content of three ampoules was mixed  and 
an aliquot of the solution equivalent to 50 mg of 
tramadol hydrochloride was quantitatively diluted 
with the supporting electrolyte solution (pH 9.3). 
Oral solution was simply diluted with the same 
electrolyte. 
In all cases, working solutions of the pharma- 
ceutical formulations were prepared exactly as the 
standard  solutions. 
 
 
2.3.4. Validation of the analytical methods 
Once the square-wave and flow injection experi- 
mental conditions were established validation of 
the methods was  performed. 
The linearity of the methods was determined by 
building five-point calibration curves in the range 
15 -75 mM and 9 -/50 mM tramadol concentrations 
for   voltammetric   and   flow   injection   method, 
respectively. 
The limit of quantification (LOQ) and the limit 
of detection (LOD) were calculated according to 
USP 25 guidelines [13]. A S/N ratio of ten and 
three was used, respectively. 
Solutions extracted from formulations at nom- 
inal concentrations of 15, 45 and 75 mM and 9, 30 
and 50 mM were analysed by the square-wave and 
FIA method, respectively. These assays were 
repeated five times in the same day to obtain 
repeatability values and five times over three 
different days to obtain intermediate precision 
values. 
In order to verify the accuracy of the method, 
recovery assays at three different concentrations 
were carried out by adding to the formulations 
known amounts of tramadol powder. The final 
nominal concentrations of tramadol were 30, 50 
and 75 mM for the voltammetric method (i.e. 
additions of 15, 35 and 60 mM to a formulation 
solution with a nominal tramadol concentration  of 
15 mM) and 19, 35 and 50 mM for the flow 
injection method (i.e. additions of 9,  25  and 40 
mM to a formulation solution with a nominal 
tramadol concentration of 10 mM). These assays 
were repeated five times over three different days 
to obtain intermediate precision   data. 
  
 
Fig.  3.  Plots  of  Ep    and  Ip    vs.  pH  from  differential  pulse 
voltammograms  of  0.1  mM  solutions  of  tramadol  in  0.1  M 
ionic strength buffer electrolyte. Scan rate 5 mV s-1. 
 
3. Results and discussion 
 
3.1. Influence of pH of supporting electrolyte 
 
Differential pulse voltammetric behaviour of 
tramadol hydrochloride (0.1 mM) at a glassy 
carbon electrode was examined varying pH over 
a wide range of values from acidic to alkaline 
media (between 1.2 and 12.8). This study led to 
conclude that tramadol is electroactive and that 
the mechanism of oxidation is dependent of pH. 
For pHs lower than 4 no oxidation peak is 
noticeable; above that value a peak is observable 
at Ep =+1.0 V vs. Ag/AgCl. The shift in the 
differential pulse peak potential as a function of 
pH  was  studied  and  a  linear  dependence was 
 
      
 
 
 
Fig. 4. Successive square-wave voltamograms in pH 9.3 0.1 M 
buffer electrolyte of tramadol: 0, 14.4, 28.8, 43.2, 57.6 and 72.0 
mM; frequency 50 Hz; pulse amplitude 50  mV. 
 
conditions for the determination of tramadol, the 
influence of parameters, such as frequency, f , and 
pulse amplitude, E s, on the current response was 
studied. 
The square-wave frequency was varied from 10 
to 200 Hz. The peak current increased with 
frequency, however above 50 Hz a decrease in 
peak   definition   is   also   observed.   Hence   this 
 
Table 1 
Analytical parameters for SWV method and flow injection 
analysis with electrochemical detection (FIA-EC) 
 
 
Parameter Method 
SWV FIA-EC 
observed  until  pH  9.3  (Fig.  3).  For  pH   higher    
than 9.3 no variation in the peak potential was 
detected. The influence of pH on the peak current 
of tramadol was also investigated. Fig. 3 shows the 
dependence of the peak current on pH. It is 
possible to observe a peak current increase until 
pH 9.3 followed by a decrease above this pH. The 
optimum pH adopted for further studies was, 
therefore, 9.3. 
 
3.2. Development of the SWV method 
 
The experimental parameters in SWV are  inter- 
Concentration range (mM) 15 -/75 9 -/50 
Calibration graph (n =5) 
Intercept (mA) 0.10 0.019 
Slope (mA mM-1) 15.5  4.90 
Correlation coefficient 0.995 0.999 
Standard  error  of intercept 0.15 0.03 
Standard  error  of slope 0.1 0.04 
LOD (mM) 2.2 1.7 
LOQ (mM) 7.3 5.7 
Intra-day  precision (RSD%)a 15 mM (2.3) 9 mM (1.2) 
45  mM (1.8) 30  mM (0.8) 
75  mM (1.4) 50  mM (0.6) 
Inter-day  precision (RSD%)a 15 mM (3.6) 9 mM (2.1) 
45  mM (2.1) 30  mM (1.9) 
75  mM (1.9) 50  mM (0.8) 
related and have a combined influence on the peak    
current. Hence, in order to establish the optimum a   Mean (n =5). 
 
 
frequency was chosen for all subsequent measure- 
ments. 
The influence of square-wave amplitude on the 
peak current was studied in the range 10 -/100 mV. 
The peak current increased until a maximum at 50 
mV and then remained constant. The square-wave 
amplitude of 50 mV was adopted for the analysis. 
With   the   optimum   experimental   conditions 
selected  the  peak  current  was  linearly  dependent 
on tramadol concentration. 
 
3.2.1. Evaluation of the method 
Standard calibration curves for tramadol hy- 
drochloride were constructed (Fig. 4). Good 
linearity was obtained over the range 15 -75 mM 
(Table 1). The LOQ and LOD, calculated accord- 
ing USP 25 guidelines [13], were 7.3 and 2.2 mM, 
respectively. Precision assays were carried out at 
three levels (15, 45 and 75 mM) and the results were 
good; the RSD% values obtained ranged from 1.4 
to 2.3% for repeatability (intra-day precision) and 
from 1.9 to 3.6% for intermediate (inter-day) 
precision (Table 1). 
 
3.3. Development of the flow injection method 
 
A single channel manifold was set-up (Fig. 2) 
and was afterwards gradually optimised with the 
purpose to allow the introduction of samples 
without pre-treatment and maximise both the 
reproducibility and sampling rate. Hence, the 
influence of several parameters such as the work- 
ing electrode potential, flow rate (Q 1), injection 
volume (A ) and the reactor length (R ) were 
studied using a 10 mM solution of   tramadol. 
 
3.3.1. Working electrode potential 
To  optimise  the  working  electrode  potential  a 
study of the variation of the peak height with the 
potential   applied   between   0.8   and   1.2   V   was 
carried  out.  The  peak  height  increased  up  to  1.0 
V and then reached a plateau over the range 1.0 -/ 
1.2 V. Beyond 1.0 V a decrease in the reproduci- 
bility of the recorder output was observed. There- 
fore, the value of 1.0 V was kept constant for the 
subsequent measurements. 
 
 
Fig. 5.  Recorder output for a series of tramadol standards  in 
mM  ((A)  9.6,  (B)  12.5,  (C)  24.0,  (D)  36.5,  (E)  48.0)  and real 
samples (F, G, H) under the conditions described for the FIA 
technique. 
 
 
 
 
3.3.2. Flow rate 
Optimisation of the flow rate was dependent on 
the characteristics of the wall-jet cell whose small 
dead volume ("'1 ml [14]) does not allow the use of 
very high flow rates. The results obtained showed 
that a flow rate of 2.4 ml min
-1  
at the entry of the 
detector  is  the  most  adequate  since  higher  flows 
produce  high  pressures  within  the  system  leading 
to  less  reproducible  analytical  signals.  Although 
lower   values   led   to   reproducible   signals   the 
sampling  rate  was  diminished.  As  a  compromise 
between  reproducibility  and  sampling  rate  a  flow 
rate of 2.4 ml min
-1  
was selected. 
 
 
3.3.3. Injection volume 
To establish the most adequate injection vo- 
lume, loops with lengths between 6 and 20 cm were 
made, using the same Teflon tubing used for the 
other parts of the system (0.8 mm i.d.), and tested. 
The use of loop lengths lower than 10 cm led to 
less reproducible signals whereas for higher lengths 
the sampling frequency was reduced. A 10 cm loop 
was therefore selected for the analysis. The sample 
volume corresponding to the chosen loop was 
accurately determined by titration of a solution of 
known concentration and this corresponded to 80 
ml [15]. 
 
Table 2 
Determination of tramadol in commercial pharmaceutical preparations using the SWV method and FIA with amperometric detector 
method (FIA-EC) 
 
Formulation Tramadol nominal content SWVa FIA-ECa 
Tramadol Asta Medica MG 50 mg ml-1 50.790.8 49.89/0.3 
Tramadol Irex† 50 mg ml-1 49.49/0.6 49.09/0.5 
Tramal† 100 50 mg ml-1 50.59/0.4 50.49/0.3 
Tramal ciclum MG 100 mg ml-1 100.09/0.9 101.690.8 
Tramadol Asta Medica MG 100 mg ml-1 97.59/0.6 100.790.4 
Tramal† 50 mg capsule-1 50.09/0.9 50.29/0.2 
Travex† 50 mg capsule-1 50.99/0.5 51.19/0.9 
Paxilfar† 100 mg tablet-1 99.09/0.8 100.69/0.9 
a   Mean and standard deviations of three determinations for different samples (mg tablet-1  or mg ml-1). 
 
3.3.4. Reactor length 
The optimisation of the reactor length (R ), in 
which the mixture of the sample plug and electro- 
lyte takes place, was also carried out. Different 
reactor lengths were tested, between 20 and 45 cm. 
The results showed less reproducible signals for 
lengths smaller than 35 cm due to insufficient 
mixing. Although higher lengths led to reproduci- 
ble signals there was an unnecessary dilution of the 
sample and a decrease of the sampling rate. Hence, 
a 35 cm reactor length was adopted for subsequent 
analysis. 
 
 
3.3.5. Evaluation of the method 
The  flow  injection  methodology  developed  led 
to  reproducible  results  (Fig.  5).  Using  the  opti- 
mised  parameters  a  calibration  curve  was  set  up 
with  standard  solutions  in  the  9 -50  mM  concen- 
tration  range  and  good  linearity  was  obtained 
(Table 1). The LOQ obtained was 5.7 mM and the 
LOD  was  1.7  mM.  Precision  assays  were  carried 
out at three levels (9, 30 and 50 mM) and the results 
were very good; RSD% values ranged from 0.6 to 
1.2%  for  repeatability  and  from  0.8  to  2.1%  for 
intermediate  precision  (Table  1).  This  manifold 
enables sampling rates of about 90 samples h
-1
. 
 
3.4. Analytical application to pharmaceutical 
dosage forms 
 
In order to assess the usefulness of the methods 
they were applied to the determination of     trama- 
dol in eight pharmaceutical dosage forms available 
in Portugal. 
For the voltammetric method, square-wave 
voltammograms were recorded for different tra- 
madol standards in the  concentration  interval 15 
to 75 mM (Fig. 4) and for the commercial samples. 
The flow injection system was calibrated by three 
replicate injections of five tramadol stan- dards in 
a concentration range between 9 and 50 mM. Fig. 
5 shows the diagram, corresponding to three 
replicate injections of five standard solutions and 
three samples, obtained in the  determination of 
tramadol hydrochloride in pharmaceutical   pre- 
parations. 
In Table 2 the mean results and the correspond- 
ing standard deviation for three replicate determi- 
nations for each dosage form are presented. The 
concentration values found were in good agree- 
ment with the labelled  amounts. 
Accuracy was assessed by means of recovery 
assays at three different concentrations (15, 35 and 
60 mM for voltammetric method and 9, 25 and 40 
mM for flow injection method); recoveries ranged 
from 97 to 102% revealing a good accuracy of the 
results. 
A systematic quantitative study was undertaken 
to verify the effect of different additives and 
excipients, which may be associated with tramadol 
in the formulations tested, using the developed 
methods. No significant interference was observed 
from the excipients commonly used such as 
sodium acetate, potassium sorbate, lactose and 
sacarose  up  to  10-fold.  These  results  show that 
 these methods are applicable to the pharmaceu- 
tical preparations available  commercially. 
 
 
 
4. Conclusions 
 
The electrochemical methods developed for the 
quantification of tramadol have proved to be a 
good alternative and advantageous over the re- 
ported analytical methods due to their sensitivity, 
rapidity and accuracy. The good recoveries  and 
low relative standard deviation reflect the high 
accuracy and precision of the proposed methods. 
Moreover, the methods are simple, easy to operate 
and inexpensive making them an excellent tool for 
the routine determination of tramadol in quality 
control laboratories. The flow injection system 
enables the determination of tramadol in   pharma- 
ceutical preparations at a rate of 90 samples h
-1
. 
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